The UAE Ministry of Health has withdrawn three medicines that may be causing cancer.
The Ministry of Health and Prevention (MoHAP) has removed all batches of Arbitense, Amopress and Hetlosar from the UAE market after they were found to contain carcinogenic properties.
Pharmacies have been instructed to return all batches of the drug back to the supplier.
The ministry also instructed the withdrawal of a US-manufactured defibrillator that failed to provide an electric current when in use.

'Dubai-it' initiative to embed Dubai’s work philosophy across generations
UAE President calls for stronger global cooperation at G7 Summit
Abu Dhabi offers 'innovative' precision therapy to treat advanced breast cancer
UAE foils drug distribution plot, dismantles criminal network
Sharjah unveils projects worth AED750 million for direct road links to Dubai
UAE President meets US President on sidelines of G7 Summit
UAE President, Greek PM discuss strategic cooperation
Emirati Media Forum to address misinformation, AI and industry transformation
